# FDA recall D-0733-2026

> **Aurobindo Pharma USA Inc** · Class II · drug recall initiated 2026-07-23.

## Product

Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-719-99

## Reason for recall

shortfill; reports of empty capsules.

## Distribution

US Nationwide.

## Key facts

- **Recall number:** D-0733-2026
- **Recalling firm:** Aurobindo Pharma USA Inc
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2026-07-23
- **Report date:** 2026-08-12

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** East Windsor, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0733-2026

## Citation

> AI Analytics. FDA recall D-0733-2026. Retrieved 2026-08-31 from https://api.ai-analytics.org/recall/D-0733-2026. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*